Saturday, July 26th, 2014
Hughes Auditorium in the Robert H. Lurie Medical Research Bldg
303 E. Superior Street, Chicago, IL 60611
SNMMI held a collaborative 1-day conference with PCRI and UsTOO (prostate patient advocacy groups) to educate patients about new therapies and tracers available for prostate cancer patients. To see the recordings, please click on the titles below.
Agenda
Welcome Gary Dillehay, MD SNMMI Immediate Past-President Professor, Dept. of Radiology, Northwestern University & Memorial Hospital
|
Your Chicago Support Tom Kirk CEO and President of Us TOO International
|
Patient Empowerment Perspective Jan Manarite PCRI Senior Educational Facilitator (Moderator)
|
“Multiparametric” MRI – Targeted Biopsies & Focal Therapy Aytekin Oto, MD Professor of Radiology and Surgery University of Chicago
(no recording available)
|
New Test for Prostate Cancer Risk and Aggressiveness William Catalona, MD Professor of Urology, Director of Clinical Prostate Cancer Program Robert H. Lurie Comprehensive Cancer Center of Northwestern University
|
Finding Metastases: PET Scans in 2014 Michael M. Graham, MD Professor of Radiology, Director of Nuclear Medicine University of Iowa College of Medicine in Iowa City
|
A Treatment Option for Bone Metastases in Prostate Cancer Michael Tomblyn, MD Senior Medical Director at Bayer HealthCare
(no recording available)
|
Targeting Side Effects From Hormone Therapy: What Helps? Tracey Thomas, ND Manager of Naturopathic Residency Cancer Treatment Centers of America, Chicago
|